Follistatin-344 peptide vial
📈 Growth Hormone

Follistatin-344

Follistatin-344 (FST-344)

Also called Follistatin-344, FS-344, FST

The body's own myostatin blocker, studied mostly as gene therapy

Follistatin is the body's own myostatin blocker. Myostatin is the brake on muscle growth, and follistatin takes it off. Preclinical models engineered to overproduce it grow strikingly muscular, which is where the interest comes from, and almost all of that work is gene therapy rather than an injected peptide.

A naturally occurring protein that binds and neutralises myostatin and activin, the body's built-in limiters on muscle growth. Interest in it comes from preclinical and gene-therapy research on muscle; no human trial has tested injected follistatin, and it is not an approved medicine.

Route studied
Gene therapy (human studies)
Status
Not FDA-approved
Emerging Evidence

Human trials published, with more underway

What Follistatin-344 has been studied for

The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.

Muscle growth
The reason people look it up. Blocking myostatin removes a ceiling the body normally imposes, and the preclinical images that circulate are the reason it has a reputation at all. No human trial of injected follistatin exists.
Muscle-wasting conditions
Where the legitimate research sits, in muscular dystrophy and similar. Those programmes use gene therapy, not an injectable peptide.

Mechanism of Action

How Follistatin-344 works

Follistatin works by neutralising growth-limiting signals in the TGF-beta family:

  • Myostatin binding. It binds circulating myostatin and blocks it from activating its receptor, lifting a brake on muscle fibre growth.
  • Activin binding. It also binds activin, a related signal, broadening its effect on the growth-suppression pathway.
  • Muscle stem cells. In preclinical work, with myostatin signalling reduced, muscle stem cell activity and protein synthesis are less restrained.

Follistatin-344 side effects: what studies reported

Very little documented, and the gap between what people expect and what is documented is wide.

Reported outside trials

  • Injection-site reactions

The honest concern

  • Myostatin limits muscle growth for reasons, and heart muscle is muscle. Sustained blockade has raised questions in preclinical work about the heart and tendons that no human study has answered
  • Products sold under the name are not the gene-therapy constructs that were studied, and their content is unverified

Source: Preclinical and gene-therapy research; no human trial of injected follistatin. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about Follistatin-344 belong with a licensed clinician who knows your history.

Your Genetics & Follistatin-344

The genes involved in how Follistatin-344 works

Follistatin-344 works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.

MSTNMyostatin (growth limiter)

The K153R variant in the myostatin gene has been studied for its association with muscle traits in human populations, with mixed results. No study has tested whether it changes response to follistatin.

Chromosome 11Fast-twitch muscle fiber (R577X)

ACTN3 · ••

The R577X variant determines whether alpha-actinin-3 is made in fast-twitch fibres, and is associated with sprint and power performance in athlete studies. It has not been studied with follistatin.

IGF1IGF-1 anabolic drive

This promoter variant has been associated with differences in baseline IGF-1 levels in population studies. Pathway context only.

Chromosome 12Vitamin D receptor (muscle FokI)

VDR · ••

The FokI variant in the vitamin D receptor has been studied for its association with muscle strength, with mixed results. Pathway context only.

The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.

Which of these variants do you carry?

Your report reads the DNA file you already have against this research.

Read my DNA, $99

Often discussed alongside

Compounds that come up next to Follistatin-344 in research and discussion. Each has its own page. None of this is a suggestion to combine them.

ACE-031

also blocks myostatin signallingEmerging Evidence

ACE-031 (Ramatercept)

A soluble decoy version of the activin receptor type IIB (ActRIIB). It circulates and binds myostatin and related growth-limiting signals before they can reach muscle. It reached human trials in Duchenne muscular dystrophy and was discontinued over bleeding and blood-vessel side effects. It is not an approved medicine.

4

Gene variants

15+

Studies

Bimagrumab

blocks the activin type II receptorEmerging Evidence

Bimagrumab (Anti-ActRII Monoclonal Antibody)

Most weight drugs reduce appetite. Bimagrumab does something different: it blocks a signal that stops muscle growing past a point. In a phase 2 trial, participants lost about a fifth of their body fat while gaining lean mass, the opposite of what usually happens with weight loss. It is an antibody given by intravenous infusion in trials, and it is not approved.

3

Gene variants

15+

Studies

Access

Access and legal status

Follistatin-344 is not an FDA-approved drug. Products sold online as “research chemicals” are labelled not for human use, and FDA treats them as unapproved drugs when they are marketed for people. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.

Your DNA and Follistatin-344: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →

Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.

Worth knowing about Follistatin-344

Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.

The famous results are gene therapy, not injections
The muscular preclinical models people have seen came from genetic modification producing follistatin continuously. An injected protein is a different thing entirely.
Tendons do not grow with the muscle
The consistent worry with anything that removes the brake on muscle: connective tissue does not keep pace, and that mismatch is where injuries happen.

Last updated

Frequently Asked Questions

How does follistatin affect muscle?

It removes a brake rather than building muscle directly. Myostatin is a protein the body produces to limit muscle growth, and follistatin binds and neutralises it (and activin). In preclinical gene-therapy studies that led to large muscle gains. No human trial has tested injected follistatin.

Has follistatin been tested in people?

Only as gene therapy, in small studies of muscle-wasting conditions such as Becker muscular dystrophy. No human trial has tested the injectable protein, and it is not an approved medicine.

Do genes affect follistatin response?

No study has tested whether any genotype changes response to follistatin. MSTN, ACTN3, IGF1 and VDR variants have been studied for their association with muscle traits, with mixed results. A DNA report can show which versions you carry and what that research does and does not show.

Your DNA and Follistatin-344

What the research says about your variants.

The report

Which Follistatin-344 variants do you carry?

Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.

Read my DNA, $99
Upload your DNA